Parallax Volatility Advisers, L.P. Invitae Corp Put Options Transaction History

Parallax Volatility Advisers, L.P.

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $336,561 - $521,160	-12,900 Reduced 37.61%	21,400 $722,000
Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $3.56 Million - $6.13 Million	-107,600 Reduced 75.83%	34,300 $1.31 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $5.55 Million - $8.15 Million	141,900 New	141,900 $5.93 Million
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $613,713 - $901,180	-15,700 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $255,870 - $402,030	9,000 Added 134.33%	15,700 $680,000
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $3,513 - $9,087	300 Added 4.69%	6,700 $202,000
Q1 2020 May 15, 2020	SELL	$7.64 - $27.5 $1.02 Million - $3.67 Million	-133,600 Reduced 95.43%	6,400 $87,000
Q4 2019 Feb 14, 2020	SELL	$15.02 - $20.57 $841,120 - $1.15 Million	-56,000 Reduced 28.57%	140,000 $2.26 Million
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $2.64 Million - $3.85 Million	140,000 Added 250.0%	196,000 $3.78 Million
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $972,720 - $1.47 Million	56,000 New	56,000 $1.32 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.